Gut health breakthrough? probiotic trial targets high blood pressure

NCT ID NCT07206303

First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 35 times

Summary

This early-stage study tests whether a probiotic supplement containing Bifidobacterium can help lower blood pressure in 30 middle-aged Chinese adults with untreated hypertension. Participants will take the probiotic for 12 weeks, and researchers will measure changes in blood pressure. The goal is to see if this approach is worth testing in a larger trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of Hong Kong

    Hong Kong, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.

Standardized tags

Added by Cure My Disease

We match each trial to standard medical vocabularies so it's findable however the registrant phrased it. These tags are added by us and may differ from the conditions listed above.

Disease matches (MONDO)

hypertensive disorder

MeSH topics

Hypertension